TYRA

39.61

3.47% 1.33

Handel nachbörslich: 39.61

Tyra Biosciences Inc (TYRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$38.28

Offen:

$37.16

24-Stunden-Volumen:

1.05M

Relative Volume:

1.13

Marktkapitalisierung:

$2.13B

Einnahmen:

Nettoeinkommen (Verlust:

$-119.95M

KGV:

-19.68

EPS:

-2.0123

Netto-Cashflow:

$-95.28M

1W Leistung:

+4.15%

1M Leistung:

+21.80%

6M Leistung:

+195.82%

1J Leistung:

+357.92%

1-Tages-Spanne:

$37.10

$40.00

1-Wochen-Bereich:

$34.01

$40.65

52-Wochen-Spanne:

$6.42

$40.65

Tyra Biosciences Inc Stock (TYRA) Company Profile

Firmenname

Tyra Biosciences Inc

Sektor

Healthcare (1118)

Branche

Biotechnology (624)

Telefon

(619) 728-4760

Adresse

2656 STATE STREET, CARLSBAD

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-26

Neueste SEC-Einreichungen

TYRA's Discussions on Twitter

Compare TYRA vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TYRA Tyra Biosciences Inc	39.61	2.13B	0	-119.95M	-95.28M	-2.0123
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-24	Eingeleitet	Cantor Fitzgerald	Overweight
2026-02-10	Eingeleitet	William Blair	Outperform
2026-01-28	Eingeleitet	Barclays	Overweight
2025-09-03	Eingeleitet	Raymond James	Strong Buy
2025-05-21	Fortgesetzt	Piper Sandler	Overweight
2025-01-07	Eingeleitet	UBS	Buy
2024-10-18	Hochstufung	BofA Securities	Neutral → Buy
2024-08-15	Eingeleitet	Piper Sandler	Overweight
2023-12-15	Herabstufung	BofA Securities	Buy → Neutral
2023-06-30	Eingeleitet	Wedbush	Outperform
2023-02-03	Eingeleitet	Oppenheimer	Outperform
2022-06-23	Eingeleitet	H.C. Wainwright	Buy
2022-03-08	Hochstufung	Jefferies	Hold → Buy
2021-11-08	Herabstufung	Jefferies	Buy → Hold
2021-10-11	Eingeleitet	BofA Securities	Buy
2021-10-11	Eingeleitet	Cowen	Outperform
2021-10-11	Eingeleitet	Jefferies	Buy

Alle ansehen

Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten

01:03 AM

Growth Stocks To Watch Now – April 3rd - Defense World

01:03 AM

Apr 04, 2026

A Look At Tyra Biosciences (TYRA) Valuation After $126 Million Stock Sale And Late Stage Trial Progress - Yahoo Finance

Apr 04, 2026

Promising Growth Stocks To Watch Today – April 2nd - Defense World

Apr 04, 2026

Apr 03, 2026

Tyra Biosciences announces $126 million stock sale in block transaction - Investing.com

Apr 03, 2026

Apr 02, 2026

Tyra Bioscience Strengthens Financial Leadership with New Officer - TipRanks

Apr 02, 2026

Tyra Biosciences (TYRA) VP details multi-year stock option grants - Stock Titan

Apr 02, 2026

Tyra Biosciences names Julia Rueb principal accounting officer, succeeding Alan Fuhrman - TradingView

Apr 02, 2026

Tyra Biosciences (NASDAQ: TYRA) taps Julia Rueb as principal accounting officer - Stock Titan

Apr 02, 2026

Tyra Biosciences stock hits all-time high at 39.21 USD By Investing.com - Investing.com South Africa

Apr 02, 2026

Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛

Apr 02, 2026

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 02, 2026

Growth Stocks Worth Watching – March 31st - Defense World

Apr 02, 2026

Apr 01, 2026

Precision Trading with Tyra Biosciences Inc. (TYRA) Risk Zones - Stock Traders Daily

Apr 01, 2026

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans - 富途牛牛

Mar 31, 2026

Mar 29, 2026

Wedbush maintains Tyra Biosciences (TYRA) outperform recommendation - msn.com

Mar 29, 2026

Mar 28, 2026

Tyra Biosciences (NASDAQ:TYRA) Director Sells $528,486.15 in Stock - MarketBeat

Mar 28, 2026

Tyra Biosciences director Kaplan sells shares worth $528k By Investing.com - Investing.com Australia

Mar 28, 2026

Mar 27, 2026

Tyra Biosciences director Kaplan sells shares worth $528k - Investing.com

Mar 27, 2026

Tyra Biosciences (NASDAQ: TYRA) director exercises 67,467 options, sells and returns shares - Stock Titan

Mar 27, 2026

Mar 26, 2026

Insider plans sale of 53,172 TYRA shares via option exercise (TYRA) - Stock Titan

Mar 26, 2026

Piper Sandler reiterates Tyra Biosciences stock rating on oral therapy potential - Investing.com Canada

Mar 26, 2026

Mar 25, 2026

[144] Tyra Biosciences, Inc. SEC Filing - Stock Titan

Mar 25, 2026

Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ - openPR.com

Mar 25, 2026

Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline - openPR.com

Mar 25, 2026

Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - Barchart

Mar 25, 2026

Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com

Mar 25, 2026

Highs Report: Is Tyra Biosciences Inc forming a breakout patternChart Signals & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Mar 25, 2026

Non Muscle Invasive Bladder Cancer Pipeline Expands As 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds Delveinsight CG Oncology, Janssen, Tyra Biosciences, Urogen Pharma - Mena FN

Mar 25, 2026

Mar 24, 2026

Dabo gratinib designation honors key Tyra Biosciences executives - tradersunion.com

Mar 24, 2026

Mar 23, 2026

Tyra Biosciences (NASDAQ:TYRA) Trading Down 4.5%Should You Sell? - MarketBeat

Mar 23, 2026

Mar 22, 2026

Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Performance - Sahm

Mar 22, 2026

Best Growth Stocks To Follow Today – March 20th - Defense World

Mar 22, 2026

Piper Sandler Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $56.00 - Defense World

Mar 22, 2026

Mar 21, 2026

Technical Reactions to TYRA Trends in Macro Strategies - news.stocktradersdaily.com

Mar 21, 2026

Boone Capital Backs Tyra Biosciences As FGFR3 Trials Shape Outlook - Sahm

Mar 21, 2026

Cantor Fitzgerald initiates coverage of Tyra Biosciences (TYRA) with overweight recommendation - MSN

Mar 21, 2026

Mar 20, 2026

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position - AOL.com

Mar 20, 2026

Boone Capital Invests in Tyra Biosciences: $10.48M Stake AcquiredNews and Statistics - IndexBox

Mar 20, 2026

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool

Mar 20, 2026

Piper Sandler Issues Positive Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat

Mar 20, 2026

Piper Sandler Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $56 - 富途牛牛

Mar 20, 2026

Mar 19, 2026

Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Mar 19, 2026

Mar 18, 2026

Forecast Cut: Can Tyra Biosciences Inc continue delivering strong returnsIPO Watch & Smart Swing Trading Techniques - baoquankhu1.vn

Mar 18, 2026

Hedge Fund Bets: Is Tyra Biosciences Inc a strong candidate for buy and holdQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Tyra Biosciences (TYRA) CFO adds 1,376 shares via employee stock plan - Stock Titan

Mar 17, 2026

Tyra Biosciences (TYRA) CEO adds 1,463 ESPP shares, holdings reach 1.36M - Stock Titan

Mar 17, 2026

Ideas Watch: Is Tyra Biosciences Incs ROE strong enoughMarket Trend Report & Smart Money Movement Tracker - baoquankhu1.vn

Mar 17, 2026